Heart news and heart widget

Berlin Heart Inc. announced its EXCOR(R) Pediatric ventricular assist device (VAD) has received unconditional approval for the ongoing IDE clinical trial in the United States of America. The U.S Food and Drug Administration (FDA) has fully approved the Investigational Plan for the IDE study of the device.

The effectiveness of nitroglycerin is often diminished when used as a medication for chest pain and heart disease for prolonged periods. A critical finding that was revealed by scientists at the University of medicine and Dentistry of New Jersey may hold the answer to more effective treatments. Research outcomes were published recently in the prestigious international cardiovascular journal entitled Circulation Research. Annie Beuve, Ph.D.